05.19.2014
Prevent & Delay
$2,142,910.00
55 months
Phase II Clinical Trial in New Onset Type 1 Diabetes Patients
Funding to support a phase II clinical trial using a combination of two FDA-approved immunosuppressant drugs on newly diagnosed patients with type 1 diabetes.